Anna Skowrońska

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi et al. · Journal of Clinical Oncology · 2014 · 2.8K citations · Full text

Medicine, Oncology, Clinical Epidemiology +16

The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

Victoria Weston, Ceri Oldreive, Anna Skowrońska et al. · Blood · 2010 · 305 citations · Full text

Medicine, Oncology, Pharmacology +9

Mutation Status of the Residual <i>ATM</i> Allele Is an Important Determinant of the Cellular Response to Chemotherapy and Survival in Patients With Chronic Lymphocytic Leukemia Containing an 11q Deletion

Belinda Austen, Anna Skowrońska, Claire Baker et al. · Journal of Clinical Oncology · 2007 · 243 citations · Full text

Life Sciences, Genetics, Oncology +12

Biallelic <i>ATM</i> Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

Anna Skowrońska, Anton Parker, Gulshanara Ahmed et al. · Journal of Clinical Oncology · 2012 · 114 citations · Full text

Medicine, Hematology, Oncology +14

The impact of SF3B1 mutations in CLL on the DNA-damage response

G. Doreen te Raa, I. A. M. Derks, Veronika Navrkalová et al. · Leukemia · 2014 · 89 citations · Full text

Life Sciences, Genetics, Molecular Biology +14